Literature DB >> 20051779

Is methylation the key to CD10 loss?

Christos N Papandreou1, David M Nanus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20051779     DOI： 10.1097/MPH.0b013e3181c74aca

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN： 1077-4114            Impact factor:   1.289


× No keyword cloud information.
  4 in total

Review 1.  From ureteric bud to the first glomeruli: genes, mediators, kidney alterations.

Authors:  Vassilios Fanos; Cristina Loddo; Melania Puddu; Clara Gerosa; Daniela Fanni; Giovanni Ottonello; Gavino Faa
Journal:  Int Urol Nephrol       Date:  2014-09-09       Impact factor: 2.370

2.  Decreased neprilysin and pulmonary vascular remodeling in chronic obstructive pulmonary disease.

Authors:  Marilee J Wick; Erica J Buesing; Carol A Wehling; Zoe L Loomis; Carlyne D Cool; Martin R Zamora; York E Miller; Sean P Colgan; Louis B Hersh; Norbert F Voelkel; Edward C Dempsey
Journal:  Am J Respir Crit Care Med       Date:  2010-09-02       Impact factor: 21.405

3.  Anti-CD10 (56C6) is expressed variably in adrenocortical tumors and cannot be used to discriminate clear cell renal cell carcinomas.

Authors:  Ozgür Mete; Yersu Kapran; Mine G Güllüoğlu; Işin Kiliçaslan; Yeşim Erbil; Yasemin Giles Senyürek; Ferhunde Dizdaroğlu
Journal:  Virchows Arch       Date:  2010-05       Impact factor: 4.064

Review 4.  Chronic Obstructive Pulmonary Disease and the Cardiovascular System: Vascular Repair and Regeneration as a Therapeutic Target.

Authors:  Srikanth Karnati; Michael Seimetz; Florian Kleefeldt; Avinash Sonawane; Thati Madhusudhan; Akash Bachhuka; Djuro Kosanovic; Norbert Weissmann; Karsten Krüger; Süleyman Ergün
Journal:  Front Cardiovasc Med       Date:  2021-04-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.